UK markets closed

Orthofix Medical Inc. (OFIX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
14.52+0.23 (+1.61%)
At close: 04:00PM EDT
14.52 0.00 (0.00%)
After hours: 04:03PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 543.52M
Enterprise value 627.49M
Trailing P/E N/A
Forward P/E 20.04
PEG ratio (5-yr expected) 0.33
Price/sales (ttm)0.71
Price/book (mrq)0.91
Enterprise value/revenue 0.84
Enterprise value/EBITDA -7.90

Trading information

Stock price history

Beta (5Y monthly) 1.03
52-week change 3-13.31%
S&P500 52-week change 327.86%
52-week high 321.60
52-week low 39.57
50-day moving average 313.90
200-day moving average 314.80

Share statistics

Avg vol (3-month) 3441.82k
Avg vol (10-day) 3333.82k
Shares outstanding 537.41M
Implied shares outstanding 637.41M
Float 826.23M
% held by insiders 13.58%
% held by institutions 197.52%
Shares short (15 Mar 2024) 43.71M
Short ratio (15 Mar 2024) 48.44
Short % of float (15 Mar 2024) 411.28%
Short % of shares outstanding (15 Mar 2024) 49.91%
Shares short (prior month 15 Feb 2024) 43.31M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -20.28%
Operating margin (ttm)-1.98%

Management effectiveness

Return on assets (ttm)-6.30%
Return on equity (ttm)-32.36%

Income statement

Revenue (ttm)746.64M
Revenue per share (ttm)20.33
Quarterly revenue growth (yoy)64.00%
Gross profit (ttm)N/A
EBITDA -9.21M
Net income avi to common (ttm)-151.4M
Diluted EPS (ttm)-4.12
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)33.11M
Total cash per share (mrq)0.88
Total debt (mrq)134.2M
Total debt/equity (mrq)22.41%
Current ratio (mrq)2.55
Book value per share (mrq)16.11

Cash flow statement

Operating cash flow (ttm)-45.75M
Levered free cash flow (ttm)-118.37M